Tom and Jillanne will discuss recent developments in manufacturer efforts to undercut the 340B program, as well as the recent Supreme Court ruling that requires CMS refund 340B underpayments to hospitals. We’ll cover ASHP’s advocacy strategy and touch on how covered entities can protect themselves in the current climate.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.